NewAmsterdam Pharma
NewAmsterdam Pharma is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 3 tracked investors.
About NewAmsterdam Pharma
NewAmsterdam Pharma is a startup founded in 2018 based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
NewAmsterdam Pharma is a Netherlands-based biotechnology company headquartered in Naarden that develops orally administered therapies for metabolic and lipid-related conditions, including treatments for cardiovascular disease. The company is incorporated in the Netherlands and trades on NASDAQ under the ticker NAMS.
Explore NewAmsterdam Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.